Abordagem medicamentosa no tratamento da osteorradionecrose: revisão de literatura
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Osteoradionecrosis (ORN) is a complication of radiotherapy affecting patients
treated for head and neck cancer, characterized by persistent bone necrosis without
evidence of tumor recurrence. Its management may involve surgical and non-surgical
approaches, with PENTO (pentoxifylline and tocopherol) and PENTOCLO
(pentoxifylline, tocopherol, and clodronate) being promising therapeutic alternatives.
This narrative literature review analyzed studies published between 2005 and 2023 on
the use of these medications in ORN treatment. Results suggest that PENTO and
PENTOCLO promote significant clinical improvement, especially in early-stage cases,
potentially avoiding invasive surgical interventions. Factors such as smoking and
alcohol consumption negatively influence treatment response. Additionally, the liquid
formulation of PENTO may be useful for patients with post-radiotherapy dysphagia,
despite potential gastrointestinal side effects. It is concluded that drug therapy
represents an effective and accessible option, but more robust clinical studies are
needed to standardize doses and treatment duration.
Description
Keywords
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

